Evidence map›Paper›PMID 32459397›Full record

ArticleJournal of cellular and molecular medicine2020

Establishment and characterization of a novel 'double-hit' follicular lymphoma cell line, FL-SJC.

Min Chen, Guoxiong Jiang, Yichen Liu, Dongya Li, Tiantian Li, Jie Peng, Qian Jiang, Haiyan You, Rong Ba, Jinlan Pan and 8 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cellular and molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Min ChenAffiliated Hospital of Jiangsu University, Zhenjiang, China.
Guoxiong JiangAffiliated Hospital of Jiangsu University, Zhenjiang, China.
Yichen LiuAffiliated Hospital of Jiangsu University, Zhenjiang, China.
Dongya LiAffiliated Hospital of Jiangsu University, Zhenjiang, China.
Tiantian LiAffiliated Hospital of Jiangsu University, Zhenjiang, China.
Jie PengAffiliated Hospital of Jiangsu University, Zhenjiang, China.
Qian JiangAffiliated Hospital of Jiangsu University, Zhenjiang, China.
Haiyan YouAffiliated Hospital of Jiangsu University, Zhenjiang, China.
Rong BaAffiliated Hospital of Jiangsu University, Zhenjiang, China.
Jinlan PanAffiliated Hospital of Suzhou University, Suzhou, China.
Mei LiAffiliated Hospital of Jiangsu University, Zhenjiang, China.
Weiguo LongAffiliated Hospital of Jiangsu University, Zhenjiang, China.
Jinsong YanThe Second Hospital of Dalian Medical University, Dalian, China.
Yan ZhuAffiliated Hospital of Jiangsu University, Zhenjiang, China.
Yun WangState Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xiaodong XiState Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jianhua MaoState Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xiaofeng ShiAffiliated Hospital of Jiangsu University, Zhenjiang, China.ORCID 0000-0002-8547-711X
Jiangsu University · CNShanghai Jiao Tong University · CNDalian Medical University · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

About 5 per cent of follicular lymphoma (FL) cases are double-hit (DH) lymphomas. Double-hit follicular lymphoma (DHFL) cell lines can improve our understanding and drug development on FL. But there are only few DHFL cell lines. Here, we established a new MYC/BCL2 DHFL cell line, FL-SJC. The cells were obtained from the hydrothorax of a patient with MYC/BCL2 DHFL and cultured for 140 passages in vitro. FL-SJC cells demonstrated CD19

Indexed as

Biomarkers, TumorCell Line, TumorMutationAnimalsBiopsyChromosome DeletionDisease Models, AnimalDrug Resistance, NeoplasmHeterograftsHumansImmunohistochemistryImmunophenotypingIn Situ Hybridization, FluorescenceKaryotypingLymphoma, FollicularMaleBiomarkers, TumorBCL2Double-hit lymphomaFL-SJC cell lineFollicular lymphomaMYC

Identifiers

PMID32459397
PMCPMC7348184
OpenAlexW3031466173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.